What are Calibrate’s next research priorities?

Future studies will focus on medication adherence, long-term sustainability of outcomes, and identifying which patient subgroups derive the greatest benefit from GLP-1 therapy and ILI support. These insights will help refine care delivery and inform best practices for employer-sponsored obesity treatment.